Anaptysbio Inc (ANAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 26,295 | 35,206 | 94,562 | 71,308 | 58,547 |
| Marketable Securities | 386,752 | 394,280 | 336,589 | 369,933 | 384,419 |
| Receivables | 3,269 | 3,182 | 1,523 | 1,419 | 1,180 |
| TOTAL | $428,000 | $438,535 | $437,154 | $447,205 | $450,444 |
| Non-Current Assets | |||||
| PPE Net | 2,254 | 2,023 | 1,982 | 2,089 | 1,972 |
| Investments And Advances | 40,203 | 59,239 | 94,929 | 142,935 | 147,511 |
| Other Non-Current Assets | 16,869 | 17,303 | 17,727 | 18,154 | 18,576 |
| TOTAL | $59,326 | $78,565 | $114,638 | $163,178 | $168,059 |
| Total Assets | $487,326 | $517,100 | $551,792 | $610,383 | $618,503 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,521 | 4,761 | 3,168 | 2,784 | 3,006 |
| Accrued Expenses | 30,916 | 35,164 | 30,956 | 21,633 | 16,453 |
| TOTAL | $39,178 | $41,631 | $35,795 | $26,054 | $21,063 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 327,765 | 327,019 | 324,904 | 322,226 | 319,821 |
| TOTAL | $327,765 | $327,019 | $324,904 | $322,226 | $319,821 |
| Total Liabilities | $366,943 | $368,650 | $360,699 | $348,280 | $340,884 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 26,575 | 26,546 | 26,487 | 27,931 | 28,432 |
| Common Shares | 27 | 27 | 27 | 29 | 28 |
| Retained earnings | -571,885 | -534,577 | -494,732 | -450,477 | -424,064 |
| Other shareholders' equity | -2,350 | -3,611 | -3,267 | -5,246 | -6,007 |
| TOTAL | $120,383 | $148,450 | $191,093 | $262,103 | $277,619 |
| Total Liabilities And Equity | $487,326 | $517,100 | $551,792 | $610,383 | $618,503 |